A Systematic Patent Review (2008-2023) for Treatment in Pregnancy.

Curr Med Chem

Graduate Program in Pharmaceutical Sciences, Federal University of Santa Maria, UFSM, Av. Roraima no. 1000, Santa Maria, 97105-900, RS, Brazil.

Published: October 2024

AI Article Synopsis

  • Pregnant women experience significant physiological changes, increasing their risk for complications and necessitating the development of safe, effective treatments to avoid issues like premature birth and low birth weight.
  • A patent review was conducted, analyzing data from 2008 to 2023 to identify innovation trends and therapeutic strategies focused on treating diseases specific to pregnant women.
  • The study identified 32 relevant patents, with a majority originating from universities and emphasizing the use of herbal medicine combined with synthetic drugs, though there's still a notable gap in advancing safe drug development for this demographic.

Article Abstract

Introduction: During pregnancy, the woman's body undergoes anatomical and physiological changes, making this period susceptible to maternal-fetal diseases and complications. The consequences of not treating pregnant women include premature birth, low birth weight fetuses, and postnatal behavior disorders. Developing new therapies can accelerate the discovery of safe and effective drugs, contributing to designing novel natural and synthetic products to treat complications the pregnancy.

Objective: This study aimed to carry out a patent review to identify and explore trends in innovation and therapeutic strategies for treating pregnant women.

Methods: The Espacenet and WIPO databases were used, with the inclusion criteria being the keywords "pregnancy and drug" and code A61k, from 2008 to 2023, and as exclusion were the access to the patent and focus on human pregnant women.

Results: After the final screening, 32 patents were selected, with strategies for the treatment of diseases in pregnant women. Of these, 20 patents are on preclinical studies on animals and 12 on pregnant women. It was observed that universities lead the ranking of applications (17/32), and China has the highest number of patents (18/32). Most findings contain herbal medicines and/or the association of natural extracts with synthetic drugs.

Conclusion: From this perspective, new drug administration systems were also developed, which can be a promising source for obtaining new medicines for the treatment of pregnant women; however, research is still limited and shows a gap in stimulating the rapid development of safe drugs that improve the health of pregnant women.

Download full-text PDF

Source
http://dx.doi.org/10.2174/0109298673296246240410093401DOI Listing

Publication Analysis

Top Keywords

pregnant women
20
patent review
8
treating pregnant
8
pregnant
7
women
5
systematic patent
4
review 2008-2023
4
2008-2023 treatment
4
treatment pregnancy
4
pregnancy introduction
4

Similar Publications

Prenatal stress has a well-established link to negative biobehavioral outcomes in young children, particularly for girls, but the specific timing during gestation of these associations remains unknown. In the current study, we examined differential effects of timing of prenatal stress on two infant biobehavioral outcomes [i.e.

View Article and Find Full Text PDF

Importance: Climate change can adversely affect mental health, but the association of ambient temperature with psychiatric symptoms remains poorly understood.

Objective: To assess the association of ambient temperature exposure with internalizing, externalizing, and attention problems in adolescents from 2 population-based birth cohorts in Europe.

Design, Setting, And Participants: This cohort study analyzed data from the Dutch Generation R Study and the Spanish INMA (Infancia y Medio Ambiente) Project.

View Article and Find Full Text PDF

Objectives: Pathways Community Hub (PCH) programs help connect pregnant women to healthcare and social services. A scoping review of peer-reviewed studies on PCHs that reported quantitative outcomes was conducted.

Methods: A search of academic databases from 1901 to 2024 initially yielded a total of 1,312 articles, which was ultimately reduced to 4 articles after duplicates were removed, and two levels of screening were conducted to determine whether studies met the inclusion criteria of evaluating a community hub for pregnant women, was written in English, was peer-reviewed, and reported quantitative outcomes.

View Article and Find Full Text PDF

HIV-prevention efforts focusing on women of child-bearing potential are needed to end the HIV epidemic in the African region. The use of antiretroviral drugs as pre-exposure prophylaxis (PrEP) is a critical HIV prevention tool. However, safety data on new antiretrovirals during pregnancy are often limited because pregnant people are excluded from drug development studies.

View Article and Find Full Text PDF

Purpose: Pregnant and postpartum mothers with physical disabilities face discrimination in healthcare settings and high rates of maternal and obstetric complications, as well as having higher rates of lifetime depression prior to pregnancy, potentially increasing their likelihood of experiencing postpartum depression (PPD). Some studies have found higher rates of PPD in mothers with physical disabilities than in mothers without physical disabilities, with more disabling symptoms associated with worse PPD systems; however, the literature is sparse and heterogenous. This systematic review and meta-analysis advanced this area of study by evaluating the strength of the association between PPD and physical disability.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!